Arizona Oncology Associates- Biltmore Cancer Center
Phoenix, Arizona, United States
Oncologist in Phoenix, Arizona
2222 E Highland Ave Suite 400, Phoenix, AZ 85016
About Arizona Oncology Associates- Biltmore Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Arizona Oncology Associates- Biltmore Cancer Center
During the past decade, Arizona Oncology Associates- Biltmore Cancer Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on
average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
2007-05-01
2010-05-01
Terminated
661
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
2006-09-01
2009-08-01
Completed
849
Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin
2012-07-01
2013-05-01
Completed
354
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
2013-10-29
2017-07-10
Completed
2,139
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Arizona Oncology Associates- Biltmore Cancer Center" #1 sponsor was "Agenus Inc." with 1 trials, followed by "GOG Foundation" with 1 trials
sponsored, "Gynecologic Oncology Group" with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "NRG Oncology"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Oncology Associates- Biltmore Cancer Center"
#1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Arizona Oncology Associates- Biltmore Cancer Center
According to Clinical.Site data, the most researched conditions in "Arizona Oncology Associates- Biltmore Cancer Center" are
"Breast Adenocarcinoma" (1 trials), "Breast Cancer" (1 trials), "Cervical Adenocarcinoma" (1 trials), "Cervical Adenosquamous Carcinoma" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "Arizona Oncology Associates- Biltmore Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Arizona Oncology Associates- Biltmore Cancer Center
Most popular intervention types in "Arizona Oncology Associates- Biltmore Cancer Center" are "Drug" (9 trials), "Other" (4 trials), "Biological" (1 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (6 trials), "Carboplatin" (3 trials), "Cyclophosphamide" (3 trials), "Laboratory Biomarker Analysis" (3 trials) and "Quality-of-Life Assessment" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Arizona Oncology Associates- Biltmore Cancer Center
The vast majority of trials in "Arizona Oncology Associates- Biltmore Cancer Center" are
6 trials for "Female" genders and 3 trials for "All" genders.
Clinical Trials Status at Arizona Oncology Associates- Biltmore Cancer Center
Currently, there are NaN active trials in "Arizona Oncology Associates- Biltmore Cancer Center".
undefined are not yet recruiting,
1 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Arizona Oncology Associates- Biltmore Cancer Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Arizona Oncology Associates- Biltmore Cancer Center, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".